Revance Therapeutics shares soar on takeover by Crown Labs

[cafead]

via Shares of Revance Therapeutics took flight in early trading Monday after the biotechnology company agreed to be acquired by privately held skincare company Crown Laboratories.

Revance shares were recently changing hands at $6.53, up about 85%.

article source